Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome

Journal of Urology

Volumn 163, Issue 1, 2000, Pages 60-62

  Herr, Harry W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bladder neoplasms; Carcinoma; Papillary

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER SURVIVAL; CYSTECTOMY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; TUMOR GROWTH;

EID: 0033992352     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67972-4     Document Type: Article

References (9)

1. Jordan, A. M., Weingarten, J. and Murphy, W. M.: Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? Cancer, 60: 2766, 1987.
2. Heney, N. M., Ahmed, S., Flanagan, M. J. et al: Superficial bladder cancer: progression and recurrence. J Urol, 130: 1083, 1983.
3. Leblanc, B., Duclos, A. J., Benard, R. et al: Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder. J Urol, 162: 1946, 1999.
4. Jakse, G., Loidl, W., Seeber, G. et al: Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol, 137: 39, 1987.
5. Herr, H. W.: Tumor progression and survival in patients with T1G3 bladder tumors: 15-year outcome. Br J Urol, 80: 762, 1997.
6. Althausen, A. F., Prout, G. R., Jr. and Daly, J. J.: Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol, 116: 575, 1976.
7. Epstein, J. I., Amin, M. B., Reuter, V. R. et al: The World Health Organization/International Society of Urulogical Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol, 22: 1435, 1998.
8. Hölmang, S., Hedelin, H., Anderstrom, C. et al: The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol, 153: 1823, 1995.
9. Haukaas, S. A., Daehlin, L., Maartmann-Moe, H. et al: Long-term outcome in patients with superficial transitional cell carcinoma of the bladder. Unpublished data.